drugset / Trial / NCT01948856

CLEARI (Clinical Efficacy Assessment on Recurrent Upper-Respiratory Tract Infections) Study

NCT01948856 ↗

Phase 3 Completed 1003 enrolled Pierre Fabre Laboratories
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess the efficacy and safety of J022X ST for prevention of Recurrent Upper-Respiratory Tract Infections (RURTI) compared to placebo in children of younger age who develop infectious diseases more frequently than other children of this age in general.

Timeline

Start
2013-09
Primary completion
2016-10-17
Completion
2016-12-13

Drugs

EvaluationDrugModalityDoseRoute
Subject J022X ST Unknown — Oral